A. B. Ackerman - Concepedia

Author

A. B. Ackerman

Also Known As

A B Ackerman, A. Ackerman, A. B Ackerman, A. B. ACKERMAN, A. B. Ackerman, A. Bernard Ackerman, A. Bernerd Ackerman, Allison Ackerman

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Columbia University Irving Medical Center Massachusetts General Hospital Dana-Farber Cancer Institute Harvard University

About

A. B. Ackerman is an author at Beth Israel Deaconess Medical Center specializing in medicine, dermatology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	274
2	Engineering	1	1	12
3	Health Sciences	1	1	33
4	Public Health	1	1	12
5	Health Informatics	1	1	12

A. B. Ackerman

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
<i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib Jochen K. Lennerz, Eunice L. Kwak, A. B. Ackerman, Journal of Clinical Oncology	2011	419
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors A. B. Ackerman, Oliver Klein, David F. McDermott, Cancer	2014	223
Follicular mucinosis. A reaction pattern in follicular epithelium. Richard H. Hempstead, A. B. Ackerman PubMed Skin DevelopmentCutaneous BiologySurgical PathologyHistopathologyReaction Pattern	1985	99
Primary acquired melanosis of the conjunctiva is melanoma in situ. A. B. Ackerman, Rohan Sood, Michelle R. Koenig PubMed	1991	58
Ancient melanocytic nevus. H. Kerl, H. Peter Soyer, Lorenzo Cerroni, PubMed	1998	51
Ideas in pathology. Malignant melanoma in situ: the evolution of a concept. B E Dubow, A. B. Ackerman PubMed	1990	39
Malignant melanoma in situ: The flat, curable stage of malignant melanoma A. B. Ackerman Pathology Surgical OncologyMedicineSurgical PathologyMelanomaCurable Stage	1985	37
Large-Cell Acanthoma Is a Solar Lentigo Hans Joachim Roewert, A. B. Ackerman American Journal of Dermatopathology	1992	34
Outcomes of patients with malignant melanoma treated with immunotherapy prior to or after vemurafenib. A. B. Ackerman, David F. McDermott, Donald P. Lawrence, Journal of Clinical Oncology ImmunologyImmunoeditingMalignant MelanomaDermatologyImmunotherapy	2012	33
EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer A. B. Ackerman, Michael A. Goldstein, Susumu Kobayashi, Journal of Thoracic Oncology Non–small-cell Lung CancerTumor BiologyOncologyMedicineEgfr Dele709_t710insd	2012	32

Page 1